Clinical trial
The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis
NCT04642274 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2021
- Completion date
- November 30, 2023
- Enrollment
- 400 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
eras